Quick Answer
Lucid Diagnostics Inc. reported Common Stock Shares Outstanding of 131.10 million shares for the year ending 2025.
- Lucid Diagnostics Inc. showed an increase of +107.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Lucid Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Lucid Diagnostics Inc.'s Common Stock Shares Outstanding has grown by 828.8%.
- Historical annual values: Fiscal year 2025: 131.10 million shares | Fiscal year 2024: 63.07 million shares | Fiscal year 2023: 42.33 million shares | Fiscal year 2022: 40.52 million shares | Fiscal year 2021: 34.92 million shares | Fiscal year 2020: 14.11 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: